Atlas Trials

Comparison of Effectiveness and Safety of Tofacitinib Versus Upadacitinib as Add-on to Methotrexate in Rheumatoid Arthritis

Clinical trial NCT07636057 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07636057
Sponsor
Sheikh Zayed Federal Postgraduate Medical Institute
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Rheumatoid Arthritis (RA)
Start date
2026-07-05
Primary completion
2027-03-05
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.